Agomelatine in Generalized Anxiety Disorder

Dan Joseph Stein; Antti Ahokas; Miguel Márquez; Cyril Höschl; Kang‐Seob Oh; Marek Jarema; А С Аведисова; Cristina Albarran; Valérie Olivier

doi:10.4088/jcp.13m08433

Related publications

Article2012

Agomelatine Prevents Relapse in Generalized Anxiety Disorder

Dan Joseph Stein, Antti Ahokas, Cristina Albarran, Valérie Olivier, Christer Allgulander

Article2008

Efficacy of Agomelatine in Generalized Anxiety Disorder

Dan Joseph Stein, Antti Ahokas, Christian de Bodinat

Article2014

Olive oil intake and risk of cardiovascular disease and mortality in the PREDIMED Study

Marta Guasch‐Ferré, Frank B Hu, Miguel Ángel Martínez‐González, Montserrat Fitó, Mònica Bulló, Ramón Estruch, Emilio Ros, Dolores Corella, Javier Recondo, Enrique Gómez‐Gracia, Miquel Fiol, José Lapetra, Lluís Serra‐Majem, Miguel Ángel Muñoz, Xavier Pintó, Rosa M. Lamuela‐Raventós, Josep Basora, Pilar Buil‐Cosiales, José V. Sorlí, Valentina Ruiz‐Gutiérrez, J. Alfredo Martínéz, Jordi Salas‐Salvadó

Article2017

Efficacy and safety of agomelatine (10 or 25 mg/day) in non-depressed out-patients with generalized anxiety disorder: A 12-week, double-blind, placebo-controlled study

Dan Joseph Stein, Antti Ahokas, Marek Jarema, А С Аведисова, L. Vavrušová, Олег Чабан, C. Gruget, Valérie Olivier, F. Picarel-Blanchot, Christian de Bodinat

Article2023

Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine

Dan Joseph Stein